Oncoinvent ASA

Director's Dealing • Nov 27, 2025

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Charles Gillies O'Bryan-Tear
2	Reason for the notification
a)	Position/status		Primary insider and chairperson of the board of directors.
b)	Initial notification /Amendment	Initial notification
3	auction monitor	Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the
a)	Business name	Oncoinvent ASA
b)	LEI code	213800TYYFXKYF3V2A23
4			Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted
a)	Description of the financial instrument/type of instrument	Shares in Oncoinvent ASA (ISIN NO0013251173)
	Identification code	ISIN: NO0013251173
b)	Nature of the transaction	Subscription of shares, partly by exercise of subscription rights with ISIN NO0013674408
c)	Price(s) and volume(s)	Currency	Price(s)	Volume(s)
		NOK 0	0.50	698,691 shares by exercise of subscription rights
		NOK	1,301,309 shares without exercise of subscription rights
		0 Sum	0	0
d)	Aggregated information - Aggregated volume - Aggregated price	Subscription of 2,000,000 shares with ISIN NO0013251173, whereas 698,691 shares are subscribed for by exercise of 698,691 subscription rights with ISIN NO0013674408 NOK 1,000,000
e)	Date of the transaction	2025-11-27
f)	Place of transaction	XOFF – Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Teakay Invest AS
2	Reason for the notification
a)	Position/status		Close associate to primary insider and member of the board of directors, Ingrid Teigland Akay.
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor
a)	Business name	Oncoinvent ASA
b)	LEI code	213800TYYFXKYF3V2A23
4	Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted
a)	Description of the financial instrument/type of instrument	Shares in Oncoinvent ASA (ISIN NO0013251173)
	Identification code	ISIN: NO0013251173
b)	Nature of the transaction	NO0013674408	Subscription of shares, partly by exercise of subscription rights with ISIN
c)	Price(s) and volume(s)	Currency	Price(s)	Volume(s)
		NOK 0	0.50	493,284 shares by exercise of subscription rights
		NOK 0.50 113,834 shares without exercise of subscription rights
		0 Sum	0	0
d)	Aggregated information - Aggregated volume - Aggregated price	Subscription of 607,118 shares with ISIN NO0013251173, whereas 493,284 shares are subscribed for by exercise of 493,284 subscription rights with ISIN NO0013674408
		NOK 303,559.00
e)	Date of the transaction	2025-11-27
f)	Place of transaction	XOFF – Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Abakus Invest AS
2	Reason for the notification
a)	Position/status		Close associate to primary insider and Chief Executive Officer, Øystein Soug.
b)	Initial notification /Amendment	Initial notification
3	auction monitor	Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the
a)	Business name	Oncoinvent ASA
b)	LEI code	213800TYYFXKYF3V2A23
4			Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted
a)	Description of the financial instrument/type of instrument	Shares in Oncoinvent ASA (ISIN NO0013251173) ISIN: NO0013251173
	Identification code
b)	Nature of the transaction	NO0013674408	Subscription of shares, partly by exercise of subscription rights with ISIN
c)	Price(s) and volume(s)	Currency	Price(s)	Volume(s)
		NOK 0	0.50	299,439 shares by exercise of subscription rights
		NOK	0.50	300,561 shares without exercise of subscription rights
		Sum 0	0	0
d)	Aggregated information - Aggregated volume - Aggregated price	Subscription of 600,000 shares with ISIN NO0013251173, whereas 299,439 shares are subscribed for by exercise of 299,439 subscription rights with ISIN NO0013674408 NOK 300,000.00
e)	Date of the transaction	2025-11-27
f)	Place of transaction	XOFF – Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Anne Cecilie Alvik
2	Reason for the notification
a)	Position/status		Primary insider and Head of Quality Assurance.
b)	Initial notification /Amendment	Initial notification
3	auction monitor		Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the
a)	Business name	Oncoinvent ASA
b)	LEI code	213800TYYFXKYF3V2A23
4			Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted
a)	Description of the financial instrument/type of instrument	Shares in Oncoinvent ASA (ISIN NO0013251173)
	Identification code	ISIN: NO0013251173
b)	Nature of the transaction	NO0013674408	Subscription of shares, partly by exercise of subscription rights with ISIN
c)	Price(s) and volume(s)	Currency	Price(s)	Volume(s)
		NOK 0	0.50	26,349 shares by exercise of subscription rights
		NOK	0.50	13,651 shares without exercise of subscription rights
		Sum 0	0	0
d)	Aggregated information
	- Aggregated volume - Aggregated price	Subscription of 40,000 shares with ISIN NO0013251173, whereas 26,349 shares are subscribed for by exercise of 26,349 subscription rights with ISIN NO0013674408
		NOK 20,000.00
e)	Date of the transaction	2025-11-27
f)	Place of transaction	XOFF – Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	HVentures Capital I AB
2	Reason for the notification
a)	Position/status	Close associate to primary insider and member of the board of directors, Ingrid Teigland Akay.
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor
a)	Business name	Oncoinvent ASA
b)	LEI code	213800TYYFXKYF3V2A23
4		Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted
a)	Description of the financial instrument/type of instrument Identification code	Financial instruments/subscription rights (ISIN NO0013674408) linked to shares in Oncoinvent ASA (ISIN NO0013251173) ISIN: NO0013674408
b)	Nature of the transaction		Exercise of subscription rights by subscription of shares
c)	Price(s) and volume(s)	Currency	Price(s)	Volume(s)
		NOK 0 Sum 0	0.50 0	7,996,326 subscription rights 0
d)	Aggregated information - Aggregated volume - Aggregated price	Exercise of 7,996,326 subscription rights with ISIN NO0013674408 by subscription of 7,996,326 shares with ISIN NO0013251173 NOK 3,998,163.00
e)	Date of the transaction	2025-11-27
f)	Place of transaction	XOFF – Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Hadean Capital I AS
2	Reason for the notification
a)	Position/status	Close associate to primary insider and member of the board of directors, Ingrid Teigland Akay.
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor
a)	Business name	Oncoinvent ASA
b)	LEI code	213800TYYFXKYF3V2A23
4		Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted
a)	Description of the financial instrument/type of instrument Identification code	Financial instruments/subscription rights (ISIN NO0013674408) linked to shares in Oncoinvent ASA (ISIN NO0013251173) ISIN: NO0013674408
b)	Nature of the transaction		Exercise of subscription rights by subscription of shares
c)	Price(s) and volume(s)	Currency	Price(s)	Volume(s)
		NOK 0 0 Sum	0.50 0	17,629,597 subscription rights 0
d)	Aggregated information - Aggregated volume - Aggregated price	Exercise of 17,629,597 subscription rights with ISIN NO0013674408 by subscription of 17,629,597 shares with ISIN NO0013251173 NOK 8,814,798.50
e)	Date of the transaction	2025-11-27
f)	Place of transaction	XOFF – Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Olav Hellebø
2	Reason for the notification
a)	Position/status		Primary insider and member of the board of directors.
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor
a)	Business name	Oncoinvent ASA
b)	LEI code	213800TYYFXKYF3V2A23
4			Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted
a)	Description of the financial instrument/type of instrument	Shares in Oncoinvent ASA (ISIN NO0013251173)
	Identification code	ISIN: NO0013251173
b)	Nature of the transaction	Subscription of shares.
c)	Price(s) and volume(s)	Currency	Price(s)	Volume(s)
		NOK 0	0.50	200,000
		0 Sum	0	0
d)	Aggregated information
	- Aggregated volume	Subscription of 200,000 shares with ISIN NO0013251173.
	- Aggregated price	NOK 100,000.00
e)	Date of the transaction	2025-11-27
f)	Place of transaction	XOFF – Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Gro E. Hjellum
2	Reason for the notification
a)	Position/status		Primary insider and Chief Operating Officer.
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor
a)	Business name	Oncoinvent ASA
b)	LEI code	213800TYYFXKYF3V2A23
4			Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted
a)	Description of the financial instrument/type of instrument	Shares in Oncoinvent ASA (ISIN NO0013251173)
	Identification code	ISIN: NO0013251173
b)	Nature of the transaction	Subscription of shares, partly by exercise of subscription rights with ISIN NO0013674408
c)	Price(s) and volume(s)	Currency	Price(s)	Volume(s)
		NOK 0	0.50	79,850 shares by exercise of subscription rights
		NOK	0.50	20,150 shares without exercise of subscription rights
		Sum 0	0	0
d)	Aggregated information - Aggregated volume - Aggregated price	Subscription of 100,000 shares with ISIN NO0013251173, whereas 79,850 shares are subscribed for by exercise of 79,850 subscription rights with ISIN NO0013674408 NOK 50,000.00
e)	Date of the transaction	2025-11-27
f)	Place of transaction	XOFF – Outside a trading venue